Dr. Arun P. Wiita's lab at UCSF focuses on developing innovative therapies for acute myeloid leukemia (AML), a challenging blood cancer. Their research combines proteomics and immunotherapy techniques to identify and exploit unique surface proteins on cancer cells, aiming to create targeted treatments that are both effective and less toxic than existing options. The lab's recent work on radioimmunotherapy is poised to significantly improve patient outcomes in AML.

Dr. Zijie Sun's lab at Albert Einstein College of Medicine focuses on understanding the biological mechanisms behind prostate cancer, particularly in African American men. The research aims to explore how genetic variations in androgen signaling pathways contribute to the higher incidence and mortality of prostate cancer in this population. By using advanced animal models and cutting-edge techniques like single-cell RNA sequencing, the lab aims to uncover new strategies for prevention and treatment.

Claude Desplan's lab at New York University studies two main areas: the unique aging process in ants and the development of neural diversity in the fruit fly Drosophila. The lab investigates how environmental factors influence aging and longevity in ants, particularly focusing on the reproductive role of certain workers that can dramatically extend their lifespan. Additionally, they explore how different neurons are formed in the fly brain, looking at the various mechanisms that contribute to neural diversity and circuit formation. Through these studies, the lab aims to uncover fundamental principles of biology that may have implications for understanding aging and neural development in other animals.

Dr. Andreas Bergmann's lab at the University of Massachusetts Medical School researches how programmed cell death, or apoptosis, affects tissue health and regeneration. By studying the fruit fly Drosophila, the lab explores how dying cells can signal nearby cells to grow, potentially leading to new cancer treatments. Their work aims to understand the genetic and molecular mechanisms behind these processes, which can enhance our knowledge of diseases like cancer, where cell death and growth signaling are crucial.

Dr. Gerald R. Crabtree's lab focuses on developing innovative small molecules to treat blood cancers, specifically Diffuse Large B Cell Lymphoma (DLBCL). They employ a unique strategy to trick cancer cells into activating their own cell death mechanisms using engineered compounds that target specific genes involved in cancer growth. This research could lead to more precise and effective cancer therapies with fewer side effects.

Dr. Osama Al Dalahmah's lab at Columbia University focuses on understanding the role of astrocytes, a type of brain cell, in Alzheimer's disease. They are particularly interested in a protein called CD44 that is expressed in these cells and how it may influence the progression of the disease. The lab uses various experimental techniques to study astrocytes in both lab settings and animal models to identify potential new treatments for Alzheimer's.

Dr. Xiaowei Lu's lab at the University of Virginia focuses on understanding how specific cell structures, particularly in the auditory system and during early development, contribute to health and disease. Their research explores how hair cells in the ear process sound and how defects in these cells can lead to hearing loss. The lab also investigates mechanisms that drive the formation of the neural tube, which, when disrupted, can result in severe birth defects.

Dr. Matheus Macedo-Lima's lab at the University of Maryland focuses on understanding how we learn to improve our auditory perception through reinforcement mechanisms in the brain. By studying how the brain's reward center interacts with training in auditory tasks, the lab aims to shed light on how perception can be enhanced or restored, especially in individuals with hearing impairments. This research combines elements of neuroscience, behavior, and training to explore the plasticity of the auditory system.

Dr. Alexander V. Chervonsky's lab focuses on understanding how sex differences and diet impact autoimmune diseases, particularly Type 1 diabetes (T1D). They study the role of hormones and gut microbes in disease mechanisms and are exploring dietary interventions that may help prevent or treat these conditions. By combining experimental models and advanced computational methods, the lab aims to identify new approaches to manage autoimmune diseases that disproportionately affect women.

Dr. Thomas James Melia's lab at Yale University focuses on understanding how cells deal with stress by creating autophagosomes, which are essential organelles that encapsulate and eliminate toxic components within the cell. His lab investigates the mechanisms by which cells harvest lipids necessary for autophagosome formation, especially under conditions of stress like disease or starvation. By elucidating these processes, the lab aims to provide insights into cell biology that could impact our understanding of various diseases such as infections, neurodegeneration, and cancer.

Dr. Julie Beth Sneddon's lab at UCSF focuses on understanding how human pancreatic cells develop, specifically the beta cells that produce insulin. By studying the unique aspects of human cell development, especially through new techniques like single-cell multi-omics, the lab aims to enhance methods for creating these insulin-producing cells from stem cells. This research is vital for developing effective treatments for diabetes, a disease that affects millions worldwide.

Dr. Chenghua Gu's lab at Harvard Medical School focuses on understanding the blood-brain barrier (BBB), which protects the brain by regulating what substances can enter from the bloodstream. The lab investigates the molecular mechanisms that maintain this barrier and how it can be manipulated for drug delivery, particularly in the context of neurological disorders like Alzheimer's and Parkinson's disease. By combining genetics, imaging, and biochemical approaches, the lab aims to develop new therapies to better treat brain-related health issues.

Dr. Neil Hunter's lab at UC Davis explores the critical role of the BRCA2 protein in the process of meiosis, which is how sperm and eggs are formed. The research focuses on understanding how BRCA2 functions in ensuring accurate chromosome segregation and maintaining gamete quality. His lab combines advanced genetic, genomic, and biochemical techniques to uncover the mechanisms of BRCA2 during reproductive cell division, with implications for addressing infertility and genetic disorders.

Dr. Harry P. Selker leads the Tufts Clinical and Translational Science Institute, which focuses on enhancing clinical research and improving public health through innovative team science. The lab works with various partners to train new researchers, develop groundbreaking methods, and foster collaboration throughout the research continuum. Their ultimate goal is to bridge the gap between scientific research and practical health solutions.

Dr. David Guertin's lab focuses on understanding how brown fat helps regulate energy balance and its potential role in fighting obesity-related diseases. By studying how this type of fat metabolizes nutrients, particularly glucose, the lab aims to identify new treatments to promote healthy weight management. The research combines advanced technologies like mass spectrometry and genetics to unravel the complexities of brown fat biology.

Dr. Martha S. Cyert's lab at Stanford University focuses on understanding how calcineurin, a crucial protein involved in calcium signaling, works at cellular membranes. The research explores how calcineurin interacts with proteins through a process called S-acylation, which involves the addition of fatty acids to proteins. This work has implications for diseases such as cancer and immune disorders, as well as a better understanding of cellular processes and potential therapeutic targets.

Dr. Xuefeng Liu's lab focuses on understanding prostate and bladder cancer, particularly the differences between African-American and European-American men. They develop innovative human cell models to study cancer progression and create non-invasive methods for monitoring bladder cancer. Their research aims to improve cancer detection and treatment outcomes by exploring the biological basis of cancer disparities and enhancing cancer cell culture techniques.

Dr. Senthil Kumar Radhakrishnan's lab focuses on enhancing the effectiveness of cancer therapies, particularly through the study of proteases. They are specifically investigating the DDI2 protease, which helps cancer cells survive during treatments with proteasome inhibitors used in multiple myeloma. By identifying small molecule inhibitors of DDI2, the lab aims to improve the survival rates and treatment outcomes for cancer patients.

Dr. Brett R. Schofield's lab at Northeast Ohio Medical University investigates how the neurotransmitter acetylcholine influences hearing and auditory processing in the brain. Their research focuses on the complex circuits in the auditory system, particularly how higher brain areas modulate auditory information through cholinergic pathways. By understanding these mechanisms, the lab aims to contribute to developing therapeutic strategies for hearing-related issues.

Dr. Rytis Prekeris's lab focuses on understanding how cells maintain their structure and function, particularly in kidney cells. They study the primary cilium, a tiny organelle that helps cells sense their environment and is essential for proper kidney function. The lab investigates specific proteins that play a role in the formation of cilia and how disruptions in this process can lead to kidney diseases. Through their research, they aim to uncover the fundamental biology of cell organization and its implications for health.